Rivus Pharmaceuticals
PrivateLast Round
Series B
Sep 22, 2022
Total Funding Raised
$167M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Rivus Pharmaceuticals is a biopharmaceutical company that develops controlled metabolic accelerators aimed at enhancing cardio-metabolic health through oral small-molecule therapeutics targeting the root causes of metabolic and cardiovascular diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rivus Pharmaceuticals Comparables
Compare Rivus Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OrsoBio | 85% | |
| Roche Holding | 82% | |
| Terns Pharmaceutical | 81% | |
Rivus Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 22, 2022 | ||||
| Series A | Jul 20, 2021 |
Key People
Founding team and executive leadership
Rivus Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series B, Series A |
| Bain Capital Life Sciences | Series B |
| RA Capital Management | Series B |
| BB Biotech | Series B |
| Medicxi | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors increased 114% MoM.
- Feb 27, 2026
Allen Cunningham transitions to Chief Operating Officer.
Rivus Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rivus Pharmaceuticals's valuation, stock price, and market status.